Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Exp Dermatol. 2002 Mar;27(2):111-4.

Adverse effects with long-term cyclosporin for severe psoriasis.

Author information

1
Department of Dermatology, City of Dublin Skin and Cancer Hospital, St. Vincent's University Hospital, Dublin, Ireland. trevormarkham@hotmail.com

Abstract

The use of cyclosporin A (CSA) for the treatment of severe psoriasis is well established. However its use is limited by its adverse effects, especially nephrotoxicity. We reviewed 28 patients treated with CSA for severe psoriasis over an 11-year period. All patients were on long-term CSA treatment (median duration 55.5 months). Twenty patients developed renal impairment which required discontinuation of treatment in seven. Twelve patients' renal function stabilized on dose reduction and one improved. Sixteen patients developed hypertension. For this small group of patients with severe psoriasis, recalcitrant to other treatments, CSA afforded better quality of life which they otherwise could not enjoy. Although this comes at a cost with the development of renal impairment we feel that such patients can be continued on CSA provided that they are under the combined care of a dermatologist and a nephrologist.

PMID:
11952700
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center